Clinical and Functional Characterization of a Novel Mutation in Lamin A/C Gene in a Multigenerational Family with Arrhythmogenic Cardiac Laminopathy

Mutations in the lamin A/C gene (LMNA) were associated with dilated cardiomyopathy (DCM) and, recently, were related to severe forms of arrhythmogenic right ventricular cardiomyopathy (ARVC). Both genetic and phenotypic overlap between DCM and ARVC was observed; molecular pathomechanisms leading to the cardiac phenotypes caused by LMNA mutations are not yet fully elucidated. This study involved a large Italian family, spanning 4 generations, with arrhythmogenic cardiomyopathy of different phenotypes, including ARVC, DCM, system conduction defects, ventricular arrhythmias, and sudden cardiac death. Mutation screening of LMNA and ARVC-related genes PKP2, DSP, DSG2, DSC2, JUP, and CTNNA3 was performed. We identified a novel heterozygous mutation (c.418_438dup) in LMNA gene exon 2, occurring in a highly conserved protein domain across several species. This newly identified variant was not found in 250 ethnically-matched control subjects. Genotype-phenotype correlation studies suggested a co-segregation of the LMNA mutation with the disease phenotype and an incomplete and age-related penetrance. Based on clinical, pedigree, and molecular genetic data, this mutation was considered likely disease-causing. To clarify its potential pathophysiologic impact, functional characterization of this LMNA mutant was performed in cultured cardiomyocytes expressing EGFP-tagged wild-type and mutated LMNA constructs, and indicated an increased nuclear envelope fragility, leading to stress-induced apoptosis as the main pathogenetic mechanism. This study further expands the role of the LMNA gene in the pathogenesis of cardiac laminopathies, suggesting that LMNA should be included in mutation screening of patients with suspected arrhythmogenic cardiomyopathy, particularly when they have ECG evidence for conduction defects. The combination of clinical, genetic, and functional data contribute insights into the pathogenesis of this form of life-threatening arrhythmogenic cardiac laminopathy.

[1]  S. Torretta,et al.  Role of nuclear Lamin A/C in cardiomyocyte functions , 2014, Biology of the cell.

[2]  Jan Lammerding,et al.  Broken nuclei--lamins, nuclear mechanics, and disease. , 2014, Trends in cell biology.

[3]  T. Edvardsen,et al.  Risk prediction of ventricular arrhythmias and myocardial function in Lamin A/C mutation positive subjects. , 2014, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[4]  Fernando Antunes,et al.  Hydrogen peroxide sensing, signaling and regulation of transcription factors , 2014, Redox biology.

[5]  V. Fuster,et al.  The MOGE(S) classification for a phenotype-genotype nomenclature of cardiomyopathy: endorsed by the World Heart Federation. , 2013, Journal of the American College of Cardiology.

[6]  C. Sergi,et al.  A case of lamin A/C mutation cardiomyopathy with overlap features of ARVC: a critical role of genetic testing. , 2013, International journal of cardiology.

[7]  F. Anselme,et al.  Implantable cardioverter-defibrillators in lamin A/C mutation carriers with cardiac conduction disorders. , 2013, Heart rhythm.

[8]  Monika Mauermann,et al.  Myopathic lamin mutations impair nuclear stability in cells and tissue and disrupt nucleo-cytoskeletal coupling. , 2013, Human molecular genetics.

[9]  G. Bonne,et al.  ‘State-of-the-heart’ of cardiac laminopathies , 2013, Current opinion in cardiology.

[10]  Paco Hulpiau,et al.  Mutations in the area composita protein αT-catenin are associated with arrhythmogenic right ventricular cardiomyopathy. , 2013, European heart journal.

[11]  R. Hauer,et al.  Phospholamban R14del mutation in patients diagnosed with dilated cardiomyopathy or arrhythmogenic right ventricular cardiomyopathy: evidence supporting the concept of arrhythmogenic cardiomyopathy , 2012, European journal of heart failure.

[12]  W. Birchmeier,et al.  Sodium current deficit and arrhythmogenesis in a murine model of plakophilin-2 haploinsufficiency. , 2012, Cardiovascular research.

[13]  M. Ashworth,et al.  Mutations in the Lamin A/C gene mimic arrhythmogenic right ventricular cardiomyopathy. , 2012, European heart journal.

[14]  D. Corrado,et al.  Pathophysiology of arrhythmogenic cardiomyopathy , 2012, Nature Reviews Cardiology.

[15]  W. McKenna,et al.  Sudden Death From Genetic and Acquired Cardiomyopathies , 2012, Circulation.

[16]  H. Worman Nuclear lamins and laminopathies , 2012, The Journal of pathology.

[17]  G. Bonne,et al.  Clinical and genetic heterogeneity in laminopathies. , 2011, Biochemical Society transactions.

[18]  P. Jouk,et al.  Clinical and mutational spectrum in a cohort of 105 unrelated patients with dilated cardiomyopathy. , 2011, European journal of medical genetics.

[19]  Y. Oade,et al.  Arrhythmogenic right ventricular cardiomyopathy , 2011, BMJ Case Reports.

[20]  Brian R. Anderson,et al.  Genetic Variation in Titin in Arrhythmogenic Right Ventricular Cardiomyopathy–Overlap Syndromes , 2011, Circulation.

[21]  J. Lötjönen,et al.  Late gadolinium enhanced cardiovascular magnetic resonance of lamin A/C gene mutation related dilated cardiomyopathy , 2011, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.

[22]  A. Keren,et al.  Genetic counselling and testing in cardiomyopathies: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. , 2010, European heart journal.

[23]  Wojciech Zareba,et al.  Diagnosis of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: Proposed Modification of the Task Force Criteria , 2010, European heart journal.

[24]  B. Loeys,et al.  Expanding the phenotype of sudden cardiac death-An unusual presentation of a family with a Lamin A/C mutation. , 2010, International journal of cardiology.

[25]  S. Julia,et al.  Validation of high-resolution DNA melting analysis for mutation scanning of the LMNA gene. , 2009, Clinical biochemistry.

[26]  E. Markiewicz,et al.  Dynamic complexes of A-type lamins and emerin influence adipogenic capacity of the cell via nucleocytoplasmic distribution of β-catenin , 2009, Journal of Cell Science.

[27]  Carlos A. Dumont,et al.  Sudden death in a patient with lamin A/C gene mutation and near normal left ventricular systolic function. , 2008, International journal of cardiology.

[28]  Y. Pinto,et al.  Severe myocardial fibrosis caused by a deletion of the 5' end of the lamin A/C gene. , 2007, Journal of the American College of Cardiology.

[29]  A. Jovanovic,et al.  High glucose protects single beating adult cardiomyocytes against hypoxia. , 2006, Biochemical and biophysical research communications.

[30]  Y. Pinto,et al.  Primary prevention of sudden death in patients with lamin A/C gene mutations. , 2006, The New England journal of medicine.

[31]  L. Monserrat,et al.  Familial dilated cardiomyopathy and isolated left ventricular noncompaction associated with lamin A/C gene mutations. , 2004, The American journal of cardiology.

[32]  M. Komajda,et al.  Apical left ventricular aneurysm without atrio‐ventricular block due to a lamin A/C gene mutation , 2003, European journal of heart failure.

[33]  L. Mestroni,et al.  Natural history of dilated cardiomyopathy due to lamin A/C gene mutations. , 2003, Journal of the American College of Cardiology.

[34]  Eloisa Arbustini,et al.  Autosomal dominant dilated cardiomyopathy with atrioventricular block: a lamin A/C defect-related disease. , 2002, Journal of the American College of Cardiology.

[35]  K. Shivkumar,et al.  Apoptosis in the genesis of cardiac rhythm disorders. , 2001, Cardiology clinics.

[36]  J. Seidman,et al.  Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction-system disease. , 1999, The New England journal of medicine.

[37]  A. R. Wright,et al.  Cardiac cell volume: crystal clear or murky waters? A comparison with other cell types. , 1998, Pharmacology & therapeutics.

[38]  N. Chandel,et al.  Intracellular Signaling by Reactive Oxygen Species during Hypoxia in Cardiomyocytes* , 1998, The Journal of Biological Chemistry.

[39]  A. Angelini,et al.  In vivo evidence of apoptosis in arrhythmogenic right ventricular cardiomyopathy. , 1998, The American journal of pathology.

[40]  R. Frank,et al.  Evidence of apoptosis in arrhythmogenic right ventricular dysplasia. , 1996, The New England journal of medicine.

[41]  T. N. James,et al.  Normal and abnormal consequences of apoptosis in the human heart: from postnatal morphogenesis to paroxysmal arrhythmias. , 1994, Transactions of the American Clinical and Climatological Association.

[42]  A. Nava,et al.  Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Task Force of the Working Group Myocardial and Pericardial Disease of the European Society of Cardiology and of the Scientific Council on Cardiomyopathies of the International Society and Federation of Cardiology. , 1994, British heart journal.

[43]  R. Płoski,et al.  Lamin A/C mutations in dilated cardiomyopathy. , 2014, Cardiology journal.

[44]  G. Danieli,et al.  Multiple mutations in desmosomal proteins encoding genes in arrhythmogenic right ventricular cardiomyopathy/dysplasia. , 2010, Heart rhythm.

[45]  H. Crijns,et al.  Meta-analysis of clinical characteristics of 299 carriers of LMNA gene mutations: do lamin A/C mutations portend a high risk of sudden death? , 2004, Journal of Molecular Medicine.